A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used gadolinium agents have been found to produce adverse effects in patients with impaired kidney function.
A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used gadolinium agents have been found to produce adverse effects in patients with impaired kidney function.
Share this Article
Recommended